Abstract:Ti‐based radiocatalytic nanomaterials, including MXenes, metal–organic frameworks and inorganic metal oxides, are explored for their potential to enhance X‐ray therapy and compared to traditionally used high‐Z nanoparticles. The radioenhancement efficacies are quantified based on metal uptake in fibrosarcoma cancer cells and mechanisms are studied using acellular 2′,7′‐dichlorofluorescein and in vitro DMSO radical quenching as well as DNA damage assays. Nanoparticle radioenhancement offers a promising strategy for augmenting radiotherapy by locally increasing radiation damage to tumor tissue. While past research has predominantly focused on nanomaterials with high atomic numbers, such as Au and HfO2, recent work has revealed that their radioenhancement efficacy decreases considerably when using clinically relevant megavoltage X‐rays as opposed to the orthovoltage X‐rays typically employed in research settings. Here, radiocatalytically active Ti‐based nanomaterials for clinical X‐ray therapy settings are designed. A range of candidate materials, including TiO2 (optionally decorated with Ag or Pt nanoseeds), Ti‐containing metal–organic frameworks (MOFs), and 2D Ti‐based carbides known as Ti3C2Tx MXenes, is investigated. It is demonstrated that these titanium‐based candidates remain consistently performant across a wide energy spectrum, from orthovoltage to megavoltage. This sustained performance is attributed to the catalytic generation of reactive oxygen species, moving beyond the simple physical dose enhancements associated with photoelectric effects. Beyond titania, emergent materials like titanium‐based MOFs and MXenes exhibit encouraging results, achieving dose‐enhancement factors of up to three in human soft tissue sarcoma cells. Notably, these enhancements are absent in healthy human fibroblast cells under similar conditions of particle uptake, underscoring the selective impact of titanium‐based materials in augmenting radiotherapy across the clinically relevant spectral range.

Auger Electrons Constructed Active Sites on Nanocatalysts for Catalytic Internal Radiotherapy

Structure-oriented catalytic radiosensitization for cancer radiotherapy

Platinum Nanoparticles to Enable Electrodynamic Therapy for Effective Cancer Treatment.

Catalytic Radiosensitization: Insights from Materials Physicochemistry

A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy

Self‐Driven Electric Field Control of Orbital Electrons in AuPd Alloy Nanoparticles for Cancer Catalytic Therapy

Catalytically Active Ti‐Based Nanomaterials for Hydroxyl Radical Mediated Clinical X‐Ray Enhancement

Scintillator-based Radiocatalytic Superoxide Radical Production for Long-Term Tumor DNA Damage

Biomimetic Nanoreactor of Catalase and Nitric Oxide Enhance Peroxynitrite Generation for Radiosensitization

Self-cascade catalytic single-atom nanozyme for enhanced breast cancer low-dose radiotherapy

Enhanced Generation of Non-Oxygen Dependent Free Radicals by Schottky-type Heterostructures of Au-Bi2S3 Nanoparticles Via X-ray-Induced Catalytic Reaction for Radiosensitization

Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H<sub>2</sub>O<sub>2</sub> for Catalytic Cascade-Amplified Tumor Therapy

Regulating Electron Transportation by Tungsten Oxide Nanocapacitors for Enhanced Radiation Therapy

A Bimetallic Nanocatalyst for Light-Free Oxygen Sensitization Therapy

Engineering Single-Atom Iron Nanozymes with Radiation-Enhanced Self-Cascade Catalysis and Self-Supplied H2O2 for Radio-enzymatic Therapy

Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects

Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H2O2 for Catalytic Cascade-Amplified Tumor Therapy

X-ray triggered scintillator versatile nanocatalytic platform for synergistic photodynamic/chemodynamic therapy

Tumor-Microenvironment-Activated NIR-II Nanotheranostic Platform for Precise Diagnosis and Treatment of Colon Cancer

A Core/Satellite Multifunctional Nanotheranostic for in Vivo Imaging and Tumor Eradication by Radiation/Photothermal Synergistic Therapy

Radiotherapy Mediated Catalytic Prodrug Therapy with Higher Radiochemical Conversion than Hydrated Electrons